The EU project PET3D (PET Imaging in Drug Design and Development) is a new Innovative Training Network (ITN) funded (€4M) by the European Commission under the H2020 – MSCA-ITN-2015 programme, and coordinated by Professor Matteo Zanda at the University of Aberdeen.

PET3D is run by a Consortium of Universities and Industries operating in the Pharma sector with the aim to provide excellent, interdisciplinary and cross-sectorial training in Drug Design and Development within an innovative PhD programme for 15 Early Stage Researchers (ESRs).

All of the ESRs recruited by PET3D will be exposed to a variety of highly complementary research environments spanning different therapeutic areas: oncology, cardiovascular, neuroscience and all of the ESRs will spend at least one secondment in a different country and will have the opportunity to attend training events and consortium meetings in all of the 7 countries involved in PET3D.

Applications are now open for two positions at Westfaelische Wilhelms Universitaet Muenster (Germany):

PhD Fellow: ESR11 ‘Multi-modal and multi-tracer imaging of inflammation in stroke. Secondment: 6 months at IMANOVA, Sweden (month 12)

PhD Fellow: ESR12 ‘Multimodal two-photon microscopy and PET/MR imaging of glioma growth & angiogenesis’. Secondment: 6 months at AstraZenaca, UK (month 6)

,

For details of these positions, go to http://www.abdn.ac.uk/pet3d/recruitment/esr11/

The deadline for application is 31 October 2016.